CRH ($CRH) posted quarterly earnings results on Wednesday, November 5th. The company reported earnings of $2.21 per share, missing estimates of $2.25 by $0.04. The company also reported revenue of $11,069,000,000, missing estimates of $11,234,938,262 by $-165,938,262.
You can see Quiver Quantitative's $CRH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CRH Insider Trading Activity
CRH insiders have traded $CRH stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CRH stock by insiders over the last 6 months:
- RANDY LAKE (Chief Operating Officer) sold 40,000 shares for an estimated $4,436,392
- PADRAIG ORIORDAIN (Group General Counsel) purchased 1,492 shares for an estimated $147,940
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CRH Hedge Fund Activity
We have seen 468 institutional investors add shares of CRH stock to their portfolio, and 409 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG removed 4,269,905 shares (-43.0%) from their portfolio in Q2 2025, for an estimated $391,977,279
- NORGES BANK removed 4,056,227 shares (-27.0%) from their portfolio in Q2 2025, for an estimated $372,361,638
- BARCLAYS PLC removed 3,781,534 shares (-33.1%) from their portfolio in Q2 2025, for an estimated $347,144,821
- AMUNDI removed 2,956,260 shares (-37.0%) from their portfolio in Q2 2025, for an estimated $271,384,668
- VICTORY CAPITAL MANAGEMENT INC added 2,887,283 shares (+1362.0%) to their portfolio in Q2 2025, for an estimated $265,052,579
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 2,874,382 shares (-23.3%) from their portfolio in Q2 2025, for an estimated $263,868,267
- CAPITAL WORLD INVESTORS added 2,609,986 shares (+90.7%) to their portfolio in Q2 2025, for an estimated $239,596,714
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CRH Congressional Stock Trading
Members of Congress have traded $CRH stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CRH stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CRH Analyst Ratings
Wall Street analysts have issued reports on $CRH in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 10/20/2025
- Wells Fargo issued a "Overweight" rating on 10/08/2025
- Truist Securities issued a "Buy" rating on 10/02/2025
- RBC Capital issued a "Outperform" rating on 10/01/2025
- B of A Securities issued a "Buy" rating on 09/26/2025
- Bernstein issued a "Outperform" rating on 09/11/2025
- JP Morgan issued a "Overweight" rating on 08/26/2025
To track analyst ratings and price targets for CRH, check out Quiver Quantitative's $CRH forecast page.
CRH Price Targets
Multiple analysts have issued price targets for $CRH recently. We have seen 9 analysts offer price targets for $CRH in the last 6 months, with a median target of $131.0.
Here are some recent targets:
- Adam Seiden from Barclays set a target price of $131.0 on 10/20/2025
- Julian Radlinger from UBS set a target price of $138.0 on 10/14/2025
- Timna Tanners from Wells Fargo set a target price of $135.0 on 10/08/2025
- Keith Hughes from Truist Securities set a target price of $140.0 on 10/02/2025
- Anthony Codling from RBC Capital set a target price of $152.0 on 10/01/2025
- Michael Feniger from B of A Securities set a target price of $128.0 on 09/26/2025
- Pujarini Ghosh from Bernstein set a target price of $130.0 on 09/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
